patient treatments

Life Sciences Coalition Opposes Federal Antitrust Deal Review Changes

A New Coalition Emerges A coalition comprising Amgen Inc., Gilead Sciences Inc., Novartis AG, Merck & Co., AbbVie Inc., and…